Codes / ICD10CM / T48.4X5

T48.4X5 Adverse effect of expectorants

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of expectorants

Summary

This condition refers to harmful or unintended clinical effects resulting from the use of expectorants, which are medications designed to facilitate mucus clearance from the respiratory tract. It includes adverse reactions that occur at therapeutic or subtherapeutic doses, excluding poisoning or underdosing scenarios.

Causes

Adverse effects may arise from individual sensitivity to expectorants, drug interactions, or incorrect administration. These reactions can occur even when the medication is used as prescribed, due to factors like metabolic differences or concurrent use of other respiratory agents.

Risk Factors

  • Use of expectorants in patients with known hypersensitivity to the drug class.
  • Concurrent use of multiple medications with overlapping respiratory effects.
  • Renal or hepatic impairment affecting drug metabolism or clearance.
  • Age-related changes in drug sensitivity (e.g., in pediatric or geriatric populations).
  • History of adverse reactions to similar medications.

Symptoms

  • Nausea, vomiting, or gastrointestinal discomfort.
  • Dizziness, headache, or drowsiness.
  • Allergic reactions (e.g., rash, itching, swelling).
  • Respiratory irritation or cough (if inhaled).
  • Rarely, more severe systemic reactions depending on the specific expectorant.

Diagnosis

Diagnosis involves correlating clinical symptoms with recent expectorant use, excluding other causes. Healthcare providers may review medication history, assess for drug interactions, and consider laboratory tests if severe reactions are suspected. Documentation should specify the expectorant involved and the nature of the adverse effect.

Treatment Options

Treatment focuses on symptom management and discontinuation of the offending agent. Mild reactions may resolve with supportive care, while severe cases may require additional interventions, such as antihistamines for allergic responses or monitoring for respiratory distress.

Prognosis and Follow-Up

Most adverse effects are mild and resolve with discontinuation of the expectorant. Follow-up may be needed to monitor for delayed reactions or to adjust therapy. Prognosis is generally favorable, though individual outcomes depend on the severity of the reaction and underlying health status.

Complications

Complications are rare but may include severe allergic reactions, respiratory distress, or systemic toxicity if the adverse effect is pronounced. Prompt recognition and management reduce the risk of long-term sequelae.

Lifestyle & Prevention

  • Use expectorants as directed and avoid exceeding recommended doses.
  • Inform healthcare providers of all medications, including over-the-counter products, to prevent interactions.
  • Store medications securely to avoid accidental exposure, especially in households with children or vulnerable individuals.
  • Discontinue use and seek guidance if adverse effects occur.

When to Seek Professional Help

Seek medical attention if symptoms worsen, persist, or include signs of severe reaction (e.g., difficulty breathing, swelling, or altered mental status). Prompt evaluation is important for managing potentially serious adverse effects.

Tips for Medical Coders

This code is used for adverse effects specifically attributed to expectorants. Documentation should clearly link the clinical presentation to the expectorant and specify the nature of the adverse effect. Ensure the code is not used for poisoning, underdosing, or other unrelated scenarios. Verify that the expectorant is identified in the medical record to support accurate coding.

Book a walkthrough

T48.4X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.